Post-activation Performance EnhancementNCT07722273
Immediate Effects of Pogo Jumps on Vertical Jump Performance in Young Basketball Players
A study testing POGO-JUMP in people with Post-activation Performance Enhancement, run by Cardenal Herrera University at 1 site in Spain.
Trial summary
This study aims to examine the acute effects of a low-volume bilateral pogo jump protocol on CMJ and DJ performance, as well as its feasibility and immediate tolerance in adolescent male basketball players. Read more about this study
- Who is it for?
- Ages 15 to 18 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Post-activation Performance Enhancement
- What is being tested?
- POGO-JUMP
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 15 participants
- Where
- 1 siteSpain
- Study dates
- 21 Jul 2026to 28 Jul 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 18 years
- Men only
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- Regular structured basketball training.
- Ability to understand instructions.
- Safe execution of the jump tests after familiarization.
- Written informed consent from a parent or legal guardian, and assent from the minor.
Who cannot join
- Acute injury limiting participation.
- Lower-limb pain aggravated by jumping.
- Recent surgery or a relevant health condition.
- Inability to perform the test technique safely.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Immediate Effects of a Pogo-Jump Microdose on Vertical Jump Performance in Adolescent Basketball Players: A Randomized Crossover Pilot Study
This study aims to examine the acute effects of a low-volume bilateral pogo jump protocol on CMJ and DJ performance, as well as its feasibility and immediate tolerance in adolescent male basketball players.
Read the detailed description
This study aims to investigate whether a low-volume bilateral pogo jump protocol can induce post-activation performance enhancement (PAPE) in adolescent male basketball players. Using a randomized crossover design, participants will complete both a pogo jump intervention and a light walking control condition, with countermovement jump (CMJ) and drop jump (DJ) performance assessed before and one minute after each condition. The study will also evaluate the immediate tolerance and field feasibility of this microdose plyometric protocol.
- Conditions
- Post-activation Performance Enhancement
- Being tested
- POGO-JUMP, CONTROL
- Keywords
- Post-activation performance enhancement, plyometric exercise, pogo jumps, countermovement jump, basketball, drop jump
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
POGO-JUMPOther
Participants will perform 3 sets of 8 consecutive bilateral pogo jumps (24 ground contacts in total), with 1 min of passive recovery between sets. They will be instructed to jump with maximal intent, minimize ground contact time, and maintain relative knee extension while avoiding a deep countermovement.
CONTROLOther
Participants will walk continuously at a comfortable, low intensity for approximately 3 min, without running, jumping, or abrupt changes of pace.
| Study group | Role | What they receive |
|---|---|---|
| POGO-JUMP | Experimental | Participants will perform 3 sets of 8 consecutive bilateral pogo jumps (24 ground contacts in total), with 1 min of passive recovery between sets. They will be instructed to jump with maximal intent, minimize ground contact time, and maintain relative knee extension while avoiding a deep countermovement. Receives: Other: POGO-JUMP |
| CONTROL | Active comparator | Participants will walk continuously at a comfortable, low intensity for approximately 3 min, without running, jumping, or abrupt changes of pace. The duration will be selected to approximate that of the experimental condition. Receives: Other: CONTROL |
What is being measured
The primary outcome is the main question the study is designed to answer.
Countermovement jump (CMJ) height (cm)
Participants will stand upright with their hands on their hips and perform a self-selected countermovement followed immediately by a maximal vertical jump. Jump height (cm) will be calculated from flight time recorded using the Chronojump Boscosystem contact platform.
Measured: Baseline and immediately after the intervention
Drop jump (DJ) height (cm)
Participants will step off an 18 cm box, land with both feet simultaneously, and immediately perform a maximal vertical jump while minimizing ground contact time. Jump height (cm) will be calculated from flight time recorded using the Chronojump Boscosystem contact platform.
Measured: Baseline and immediately after the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jul 2026
- Study start21 Jul 2026
- Primary completion28 Jul 2026
- Study completion28 Jul 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Post-activation Performance EnhancementStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 15 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cardenal Herrera University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Juan F. Lisón Párraga, Dr, Cardenal Herrera University
- Investigators
- JF Lisón, Dr, Principal investigator, CEU Cardenal Herrera University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07722273
- Sponsor's protocol ID
- UNIVERSITY CARDENAL HERRERA-56
- Status last verified
- Oct 2026
- First submitted
- 20 Jul 2026
- Last updated
- 13 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 13 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Immediate Effects of a Pogo-Jump Microdose on Vertical Jump Performance in Adolescent Basketball Players: A Randomized Crossover Pilot Study
- ClinicalTrials.gov ID
- NCT07722273
- Acronym / sponsor ID
- UNIVERSITY CARDENAL HERRERA-56
- Conditions
- Post-activation Performance Enhancement
- Keywords
- Post-activation performance enhancement, plyometric exercise, pogo jumps, countermovement jump, basketball, drop jump
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 15 participants (actual)
- Lead sponsor
- Cardenal Herrera UniversityUniversity, hospital or other
- Study start
- 21 Jul 2026 (actual)
- Primary completion
- 28 Jul 2026 (actual)
- Study completion
- 28 Jul 2026 (actual)
- First posted
- 23 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to examine the acute effects of a low-volume bilateral pogo jump protocol on CMJ and DJ performance, as well as its feasibility and immediate tolerance in adolescent male basketball players.
Detailed description
This study aims to investigate whether a low-volume bilateral pogo jump protocol can induce post-activation performance enhancement (PAPE) in adolescent male basketball players. Using a randomized crossover design, participants will complete both a pogo jump intervention and a light walking control condition, with countermovement jump (CMJ) and drop jump (DJ) performance assessed before and one minute after each condition. The study will also evaluate the immediate tolerance and field feasibility of this microdose plyometric protocol.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| POGO-JUMP | Experimental | Other: POGO-JUMPParticipants will perform 3 sets of 8 consecutive bilateral pogo jumps (24 ground contacts in total), with 1 min of passive recovery between sets. They will be instructed to jump with maximal intent, minimize ground contact time, and maintain relative knee extension while avoiding a deep countermovement. |
| CONTROL | Active comparator | Other: CONTROLParticipants will walk continuously at a comfortable, low intensity for approximately 3 min, without running, jumping, or abrupt changes of pace. The duration will be selected to approximate that of the experimental condition. |
Who may qualify
- Ages
- 15 to 18 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (4 listed)
- Regular structured basketball training.
- Ability to understand instructions.
- Safe execution of the jump tests after familiarization.
- Written informed consent from a parent or legal guardian, and assent from the minor.
Key exclusion criteria (4 listed)
- Acute injury limiting participation.
- Lower-limb pain aggravated by jumping.
- Recent surgery or a relevant health condition.
- Inability to perform the test technique safely.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| POGO-JUMPParticipants will perform 3 sets of 8 consecutive bilateral pogo jumps (24 ground contacts in total), with 1 min of passive recovery between sets. They will be instructed to jump with maximal intent, minimize ground contact time, and maintain relative knee extension while avoiding a deep countermovement. | Other | POGO-JUMP |
| CONTROLParticipants will walk continuously at a comfortable, low intensity for approximately 3 min, without running, jumping, or abrupt changes of pace. | Other | CONTROL |
Primary outcome
Countermovement jump (CMJ) height (cm)
Time frame: Baseline and immediately after the intervention
Participants will stand upright with their hands on their hips and perform a self-selected countermovement followed immediately by a maximal vertical jump. Jump height (cm) will be calculated from flight time recorded using the Chronojump Boscosystem contact platform.
Drop jump (DJ) height (cm)
Time frame: Baseline and immediately after the intervention
Participants will step off an 18 cm box, land with both feet simultaneously, and immediately perform a maximal vertical jump while minimizing ground contact time. Jump height (cm) will be calculated from flight time recorded using the Chronojump Boscosystem contact platform.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Oct 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Post-activation Performance Enhancement
Enrolling by invitation
Acute Effects of Bilateral Versus Unilateral Isometric Conditioning Activity on Jump Performance in Volleyball Players
Athletic Performance, Volleyball
Active, not recruiting
Plyometrics vs PAPE Training in Football: Effects on Agility, Explosive Power and Speed
Athletic Performance, Football Players
Active, not recruiting
Post-activation Performance Enhancement in Soccer Players:
Performance, Post Activation Potentiation
Active, not recruiting
Post-Activation Performance Enhancement in Single and Multi-Joint Exercises With BFR and EMS in Male Volleyball Players
Volleyball Players, Post Activation Potentiation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
JF Lisón, Dr principal investigator
CEU Cardenal Herrera University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing POGO-JUMP in people with Post-activation Performance Enhancement, run by Cardenal Herrera University at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Countermovement jump (CMJ) height (cm) (time frame: Baseline and immediately after the intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2026.